The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patientsArticle Published on 2022-09-292022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.1017863 PMC 바로가기
Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients혈액학적 환자에서 mRNA SARS-CoV-2 백신으로의 혈청전환Article Published on 2022-05-122022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.852158 PMC 바로가기 [Article Type] Article
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trialResearch article Published on 2022-05-012022-10-05 Journal: The Lancet Rheumatology [Category] [DOI] 10.1016/S2665-9913(22)00044-3 [Article Type] Research article
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection이전 COVID-19 감염 환자에서 조혈 세포 이식이 가능합니다Article Published on 2022-01-012022-09-11 Journal: Transplantation and cellular therapy [Category] [DOI] 10.1016/j.jtct.2021.10.004 PMC 바로가기 [Article Type] Article
Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases대뇌 정맥 혈전증 및 골수 증식성 신생물: 74건의 연속 사례에 대한 3개 기관 연구Multicenter Study Published on 2021-12-012022-09-11 Journal: American journal of hematology [Category] [DOI] 10.1002/ajh.26336 PMC 바로가기 [Article Type] Multicenter Study
Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19Conference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] [DOI] 10.1182/blood-2021-151801 [Article Type] Conference abstract
The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third DoseCommunication Published on 2021-10-152022-10-28 Journal: Biomedicines [Category] [DOI] 10.3390/biomedicines9101480 PMC 바로가기 [Article Type] Communication
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future ScenariosReview Published on 2021-09-232022-10-31 Journal: Cancers [Category] [DOI] 10.3390/cancers13194750 PMC 바로가기 [Article Type] Review
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD광범위한 만성 GVHD가 있는 동종 줄기 세포 이식 후 토실리주맙 및 항바이러스제로 치료된 중증 COVID19의 임상 경과Case Reports Published on 2021-08-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] [DOI] 10.1111/tid.13576 PMC 바로가기 [Article Type] Case Reports
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia진성적혈구증가증 및 본태성 혈소판증가증에 비해 골수섬유증 환자에서 BNT162b2 백신에 대한 낮은 반응Letter to the Editor Published on 2021-07-292022-09-12 Journal: Journal of Hematology & Oncology [Category] [DOI] 10.1186/s13045-021-01130-1 PMC 바로가기 [Article Type] Letter to the Editor